Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20210622002Not yet recruiting
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine, Prince of Songkhla University. Primary endpoint: Humoral immune response to COVID-19 vaccination. Planned start Jun 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20210622002.